Advantage Alpha Capital Partners LP Bio Techne Corp Transaction History

Advantage Alpha Capital Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $7.25 Million - $9.45 Million	-29,356 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $4.9 Million - $5.97 Million	21,099 Added 255.53%	29,356 $7.27 Million
Q2 2020 Aug 13, 2020	SELL	$185.43 - $279.56 $2.3 Million - $3.46 Million	-12,380 Reduced 59.99%	8,257 $2.18 Million
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $3.33 Million - $4.57 Million	20,637 New	20,637 $3.91 Million

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.